eCardio opens independent diagnostic testing facility in California

eCardio Diagnostics, a leader in remote arrhythmia monitoring services, today announced the opening of its second Independent Diagnostic Testing Facility (IDTF) in San Francisco, California.

"This expansion, along with our continued employee and facility growth in Houston, will provide the resources for us to better serve our increasing patient population throughout the United States.  We are excited about our growth opportunities in 2014 and beyond," said eCardio's Chairman and Chief Executive Officer, Larry Lawson.

Expanding to the West Coast is a strategic focus for eCardio as it continues to widen its reach and operations across the country. 

"The IDTF in San Francisco will enable us to better serve our practices and patients as well as to provide additional support to our Houston monitoring lab," said eCardio's President and Chief Operating Officer, John Untereker.

The new IDTF will further enhance eCardio's strong presence in California and create a closer relationship with the burgeoning West Coast market.  This impressive expansion is a testament to eCardio's success and further emphasizes its commitment to providing excellent service to practices and patients nationwide.

eCardio has provided remote cardiac monitoring services since 2004, a decade of excellence and counting.  For more information about eCardio, please visit www.ecardio.com. 

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.